Skip to content
November 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Metastatic Breast Cancer Research
  • METAvivor Announces Strategic Shift: Transitioning Peer-to-Peer Fundraising to Bloomerang
  • Metastatic Breast Cancer Research

METAvivor Announces Strategic Shift: Transitioning Peer-to-Peer Fundraising to Bloomerang

Nana November 9, 2026 7 minutes read
metavivor-announces-strategic-shift-transitioning-peer-to-peer-fundraising-to-bloomerang

In a significant operational update for the metastatic breast cancer (MBC) advocacy community, METAvivor, the leading non-profit organization dedicated to funding research for stage IV breast cancer, has officially announced a transition in its digital infrastructure. The organization is migrating its Peer-to-Peer (P2P) fundraising operations from GoFundMe Pro (formerly Classy) to Bloomerang Fundraising. This move represents a long-term strategic investment aimed at streamlining donor management, enhancing the user experience for fundraisers, and ultimately accelerating the pace of vital research funding.

Main Facts: The Transition Explained

The migration to Bloomerang is not merely a change in software, but a fundamental shift in how METAvivor interacts with its grassroots supporters. Effective this fall, all fundraising activities previously hosted on the GoFundMe Pro platform will be officially sunsetted.

For the thousands of advocates, families, and patients who utilize METAvivor’s P2P tools to raise money for research, the transition is intended to be seamless. METAvivor leadership has confirmed that all existing fundraising pages have been migrated to the Bloomerang ecosystem. This ensures that historical data, donation progress, and participant information remain intact during the platform swap.

The core objective of this transition is to utilize Bloomerang’s specialized nonprofit-centric features, which are designed to improve donor retention and provide more granular analytics to the organization. By centralizing fundraising data within a platform optimized for non-profits, METAvivor aims to reduce administrative friction, allowing the organization to focus its limited resources on its primary mission: transforming metastatic breast cancer from a terminal illness into a manageable, chronic, or curable condition.

Chronology: A Roadmap for Supporters

The transition process has been carefully phased to minimize disruption for active campaigns. The timeline of this migration is as follows:

  • Early Summer 2024 (Planning Phase): METAvivor’s operations team finalized the vetting process for a new CRM and fundraising partner, identifying Bloomerang as the optimal solution for long-term scalability.
  • July 27, 2024 (The Notification Milestone): The organization initiated the transition outreach by emailing all active P2P users. This communication included critical credentials and instructions on how to access the new Bloomerang-powered dashboard.
  • Late Summer 2024 (Data Migration): Technical teams executed the transfer of existing fundraising pages, historical donor lists, and active campaign metrics to the new system.
  • Autumn 2024 (Decommissioning): The GoFundMe Pro (formerly Classy) interface is scheduled to be deactivated. By the end of this season, all fundraising activity will reside exclusively on the Bloomerang platform.
  • Ongoing Support: Following the July notification, the organization has maintained an "open-door" policy, directing any users who may have missed initial communications or encountered technical difficulties to their dedicated support team via [email protected].

Supporting Data: Why the Shift Matters

The decision to migrate platforms is rooted in the current landscape of digital philanthropy. According to recent industry reports on non-profit technology, organizations that integrate their peer-to-peer fundraising tools with robust, specialized CRM (Constituent Relationship Management) software see, on average, a 15–20% increase in donor retention rates.

METAvivor relies heavily on individual, grassroots fundraising. Unlike larger organizations that may rely on massive institutional grants, the "lifeblood" of METAvivor is the individual advocate—the daughter running a marathon in honor of a mother, the patient holding a bake sale, or the community group organizing a gala.

Data from the previous platform, while functional, lacked the specific "donor journey" automation tools that Bloomerang offers. By utilizing Bloomerang, METAvivor can now:

  1. Automate Personalized Stewardship: Ensure that donors receive immediate, meaningful acknowledgments that reflect the urgency of the MBC cause.
  2. Optimize Recurring Giving: Easily track and convert one-time donors into monthly "METAvivor Champions."
  3. Enhance Security: Implement higher-level data encryption protocols, which are paramount when handling sensitive donor information.

The efficiency gains from this transition are expected to translate directly into more research dollars. By lowering the "cost per dollar raised"—a key metric in non-profit health—METAvivor ensures that a larger percentage of every donation goes directly to the lab benches where stage IV research is conducted.

Official Responses and Organizational Vision

In statements provided regarding the transition, the sentiment from METAvivor remains focused on the patient. The organization emphasizes that while technology is the backbone of the campaign, the spirit of the advocate is the true driver of change.

"We are deeply appreciative of our community’s adaptability," a representative for METAvivor stated. "Moving platforms is a complex undertaking, but it is necessary to keep pace with the evolving needs of our supporters. Our goal is to provide a platform that is as resilient and determined as the patients we fight for every day."

The organization has made it clear that the transition is not just about convenience, but about sustainability. As metastatic breast cancer research enters a new era of immunotherapy and targeted treatments, the funding mechanism must be equally sophisticated. By aligning with Bloomerang, METAvivor is positioning itself to handle the increased volume of donations expected as awareness for MBC continues to grow on a national scale.

For those who have not yet accessed their new dashboards, the organization’s leadership urges them to prioritize the July 27 email. Should the email be lost in spam filters or buried in inboxes, the organization has dedicated personnel to verify accounts and provide secure access links, ensuring that no fundraiser’s hard work is lost in the digital shuffle.

Implications: The Future of MBC Fundraising

The implications of this move extend far beyond the technical backend. By standardizing its P2P fundraising, METAvivor is setting a new standard for how patient-led advocacy groups manage their digital presence.

Strengthening Community Bonds

Peer-to-peer fundraising is inherently social. It turns personal struggles into communal action. With the new Bloomerang interface, fundraisers will find it easier to share their stories and update their networks on their progress. This heightened visibility is expected to create a "multiplier effect," where successful campaigns inspire others to join the movement.

Data-Driven Advocacy

The new platform will provide METAvivor with better insights into where its support originates. Understanding the geographic and demographic reach of their campaigns allows the organization to tailor its advocacy efforts, ensuring that researchers are getting the funding they need in areas where medical breakthroughs are most promising.

A Call to Continued Action

As the fall season approaches and the GoFundMe Pro pages close, the message from METAvivor is one of gratitude and renewed purpose. The organization acknowledges that the transition requires effort from their volunteers, but it also underscores that this effort is a direct investment in the research that saves lives.

Metastatic breast cancer remains a disease that receives far too little funding compared to the mortality rates it causes. With nearly 100% of all breast cancer deaths caused by metastasis, every dollar raised through these P2P platforms is a potential lifeline. METAvivor’s commitment to this new platform is a commitment to ensuring that the next generation of researchers has the consistent, reliable support required to make the next great breakthrough.

Conclusion: How to Stay Involved

For those currently managing a fundraiser or planning to start one, the path forward is clear. Visit the official METAvivor website to familiarize yourself with the new fundraising dashboard. Ensure your contact information is updated, and if you encounter any roadblocks, do not hesitate to reach out to the organization directly.

As METAvivor closes the chapter on its previous platform, it opens a more robust, efficient, and technologically sound future. The mission remains unchanged, but the tools are now sharper, stronger, and better equipped to fight the battle against metastatic breast cancer. Your continued support—through this transition and beyond—is the primary reason that progress is possible.

The organization concludes with a heartfelt thank you to its community. "Your efforts are not just numbers on a screen; they are the hope of thousands of patients living with MBC today. Thank you for walking this path with us, and for ensuring that together, we continue to demand more for metastatic breast cancer research."

About the Author

Nana

Author

View All Posts

Post navigation

Previous: Revolutionary "Trojan Horse" Immunotherapy Targets Cancer’s Defenses, Offering Hope for Metastatic Solid Tumors

Related Stories

bridging-the-gap-the-visionary-public-health-advocacy-of-taylarr-lopez
  • Metastatic Breast Cancer Research

Bridging the Gap: The Visionary Public Health Advocacy of Taylarr Lopez

Asro November 9, 2026
a-legacy-of-data-driven-advocacy-the-transformative-leadership-of-lori-swain-at-the-ncra
  • Metastatic Breast Cancer Research

A Legacy of Data-Driven Advocacy: The Transformative Leadership of Lori Swain at the NCRA

Nana Muazin November 8, 2026
bridging-the-gap-tameron-harvell-and-the-future-of-precision-oncology
  • Metastatic Breast Cancer Research

Bridging the Gap: Tameron Harvell and the Future of Precision Oncology

Jia Lissa November 8, 2026

Recent Posts

  • METAvivor Announces Strategic Shift: Transitioning Peer-to-Peer Fundraising to Bloomerang
  • Revolutionary "Trojan Horse" Immunotherapy Targets Cancer’s Defenses, Offering Hope for Metastatic Solid Tumors
  • Landmark Gene Therapy Trial for Hereditary Transthyretin Amyloidosis Completes Patient Enrollment
  • Igniting Action and Fostering Hope: Your Comprehensive Guide to a Meaningful Breast Cancer Awareness Month
  • The Voice of Resilience: Roxana Guerra’s Decade-Long Journey and the Critical Mission of Metastatic Breast Cancer Advocacy

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

metavivor-announces-strategic-shift-transitioning-peer-to-peer-fundraising-to-bloomerang
  • Metastatic Breast Cancer Research

METAvivor Announces Strategic Shift: Transitioning Peer-to-Peer Fundraising to Bloomerang

Nana November 9, 2026
revolutionary-trojan-horse-immunotherapy-targets-cancers-defenses-offering-hope-for-metastatic-solid-tumors
  • Medical Research and Clinical Trials

Revolutionary "Trojan Horse" Immunotherapy Targets Cancer’s Defenses, Offering Hope for Metastatic Solid Tumors

Ammar Sabilarrohman November 9, 2026
landmark-gene-therapy-trial-for-hereditary-transthyretin-amyloidosis-completes-patient-enrollment
  • Medical Research and Clinical Trials

Landmark Gene Therapy Trial for Hereditary Transthyretin Amyloidosis Completes Patient Enrollment

Rifan Muazin November 9, 2026
igniting-action-and-fostering-hope-your-comprehensive-guide-to-a-meaningful-breast-cancer-awareness-month
  • Patient Advocacy and Support

Igniting Action and Fostering Hope: Your Comprehensive Guide to a Meaningful Breast Cancer Awareness Month

Nana November 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.